The effects of octreotide in a patient with Nelson's syndrome.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8746287.
- Also identified by PMC identifier 2398324.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We have administered octreotide, 100 micrograms tid, to a 27-year-old man with Nelson's syndrome. After seven days of therapy, adrenocorticotropin levels fell to 54% of initial values, and some shrinkage of the tumour was observed. This study indicates that octreotide therapy may have a role in the treatment of Nelson's syndrome.
Medical subject headings
- Antineoplastic Agents, Hormonal
- Nelson Syndrome
- Octreotide